Study Protocol for the MIND-PD Study
A Randomized Controlled Trial to Investigate Clinical and Biological Effects of Mindfulness-Based Cognitive Therapy in People with Parkinson’s Disease
Background: People with Parkinson’s disease (PD) are highly sensitive to stress, which can exacerbate neuropsychiatric and motor symptoms. Mindfulness-based interventions (MBIs) have shown promise in reducing stress, depression, and anxiety in PD.
Methods: The study aims to determine the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in alleviating symptoms of anxiety and depression in PD patients. A total of 124 PD patients will undergo 8 weeks of MBCT or receive care as usual, with assessments at baseline, 2 months, and 12 months. The primary outcome is the total score on the Hospital Anxiety and Depression Scale (HADS) at 2 months.
Discussion: This trial is among the first to investigate the effects of MBCT on anxiety and depression in PD over a 1-year period, as well as explore potential mechanisms underlying stress reduction in PD.
Trial Registration: ClinicalTrials.gov, NCT05779137. Registered on 12 January 2023.
Clinical Trials and AI-Driven Solutions
Clinical trials play a crucial role in developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates clinical protocols and research into a single, easily accessible knowledge base for clinicians.
Streamlining Healthcare Operations with AI
In today’s healthcare environment, streamlining operations is essential. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.
Enhancing Workflows and Patient Outcomes with AI
By utilizing AI, clinics can improve workflows, enhance patient outcomes, and reduce paper-based routines. Learn more about how we can help at aidevmd.com.
